Law360 is providing free access to its coronavirus coverage to make sure all members of the legal community have accurate information in this time of uncertainty and change. Use the form below to sign up for any of our weekly newsletters. Signing up for any of our section newsletters will opt you in to the weekly Coronavirus briefing.
Sign up for our Consumer Protection newsletter
You must correct or enter the following before you can sign up:
Thank You!
Law360 (March 24, 2021, 5:35 PM EDT ) Dr. Rachel L. Levine, one of President Joe Biden's top health care nominees, on Wednesday blazed an important trail for the LGBTQ community by becoming the first openly transgender individual to win U.S. Senate confirmation to a federal post.
Dr. Rachel L. Levine was confirmed as assistant secretary for health at the U.S. Department of Health and Human Services on Wednesday.
Quick Facts About Levine
Education: Harvard College; Tulane School of Medicine
Past employers: Pennsylvania Department of Health; Penn State College of Medicine; Penn State Hershey Medical Center
Specialties: Studies of eating disorders, adolescent medicine and psychiatry, and opioid abuse
Noteworthy: As Pennsylvania's physician general, Levine signed the first standing order streamlining access by the public and medical professionals to opioid-overdose reversal drug naloxone
Biden in January announced the nomination of Levine, at the time Pennsylvania's health secretary, and hailed her as "a historic and deeply qualified choice" for the HHS post.
"Dr. Rachel Levine will bring the steady leadership and essential expertise we need to get people through this pandemic — no matter their zip code, race, religion, sexual orientation, gender identity or disability," the president said at the time.
The entire Democratic caucus voted in favor of Levine, as did Republican Sens. Susan Collins of Maine and Lisa Murkowski of Alaska. Wednesday's vote, while close, wasn't as narrow as the 50-49 vote last week to confirm California Attorney General Xavier Becerra as HHS secretary.
Social media was abuzz with excitement in the run-up to Wednesday's vote. On Twitter, transgender rights groups — including Lambda Legal and the National Center for Transgender Equality — trumpeted her looming ascent by using the hashtag #ConfirmDrLevine.
The Senate's vote occurred amid a national conversation over transgender rights. That conversation has often featured right-leaning voices objecting to transgender females participating in female sports leagues or fretting about minors transitioning physically in accordance with their gender identity.
"At a time when hateful politicians are weaponizing trans lives for their own perceived political gain, Dr. Levine's confirmation lends focus to the contributions trans people make to our nation and deflates absurd arguments calling for their exclusion," Annise Parker, head of the LGBTQ Victory Institute, which works to elevate LGBTQ public leaders, said in a Wednesday statement.
Levine's new post gained an especially high profile last year as then-HHS Assistant Secretary for Health Brett Giroir served as the nation's testing czar for COVID-19 and became a familiar face of the Trump administration's pandemic response.
Levine's confirmation process was not without controversy. During a hearing last month at the Senate health committee, Sen. Rand Paul, R-Ky., used his questioning time to compare gender transition therapies to female genital mutilation, prompting the panel's Democratic chair to rebuke him for "ideological and harmful misrepresentations."
A graduate of Harvard College and the Tulane School of Medicine, Levine trained at the Mount Sinai Health System in New York City before moving to Pennsylvania. In the Keystone State, Levine worked at the Penn State College of Medicine before state lawmakers confirmed her to serve as secretary of health. Levine's areas of professional focus include opioid abuse, eating disorders and adolescent medicine and psychiatry, according to her prepared Senate testimony.
--Additional reporting by Britain Eakin. Editing by Marygrace Murphy.
For a reprint of this article, please contact reprints@law360.com.